/PRNewswire/ Kyverna Therapeutics, Inc. (Nasdaq: KYTX), a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies.
Kyverna Therapeutics To Attend The 2024 American Academy Of Neurology (AAN) Annual Meeting In Denver, CO, With Data On KYV-101 In The Treatment Of Pat menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
Why detecting the earliest biological signs of Parkinson s disease is so crucial stanford.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from stanford.edu Daily Mail and Mail on Sunday newspapers.
Research suggested that EBV is the primary cause of MS. What are the clinical implications, and could this transform treatment and prevention of this neurodegenerative condition?